AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Cerebral Small Vessel Disease Progression Dependent on Stroke Type

Recruitingn/aAges 18 Years - anyAllJohannes Dorst
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this prospective, observational study is to understand if cerebral small vessel disease (CSVD) has different velocities and patterns of temporal development, dependent on a concurrent ischemic stroke. It focusses on adult patients with known or newly diagnosed CSVD on magnetic resonance imaging. The study will evaluate if blood based, in parts central nervous system specific protein markers, so called biomarkers, have an additional value reflecting the course of CSVD as defined per MRI assessments. Further patient-relevant endpoints include neuropsychological abilities, neurological functional outcomes, quality of life assessments, stroke recurrence risk.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age โ‰ฅ 18 years * Evidence of cerebral small vessel disease on brain MRI, defined as white matter hyperintensities (Fazekas grade 1-3) * Assignment to one of the following study groups based on MRI findings: * cerebral small vessel disease without evidence of an acute ischemic stroke * cerebral small vessel disease with acute lacunar ischemic stroke * cerebral small vessel disease with acute territorial ischemic stroke * Ability to provide written informed consent * Sufficient German language skills to understand study procedures and assessments Exclusion Criteria: * Alternative plausible causes of white matter hyperintensities other than cerebral small vessel disease (e.g. inflammatory central nervous system disorders, leukodystrophies, brain tumors) * Known neurodegenerative diseases (e.g. Parkinson's disease, Alzheimer's disease, other dementias) * Acute or recent traumatic brain injury * Contraindications to magnetic resonance imaging * Pregnancy or breastfeeding * Life expectancy of less than one year * Inability to comply with study procedures or follow-up visits
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
University Hospital Ulm, Department of Neurology, Germany
Ulm, Germany
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy